drugs for diarrhea and constipation Flashcards

1
Q

opioid agonists

A

loperamide (immodium)
diphrenoxylate/atropine
octreotide
eluxadoline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

opioid agonists MOA

A

activation of opioid receptors in the smooth muscle of the GI tract - alters peristalsis by preventing smooth muscle contraction and relaxation - reduces stool volume and prevents electrolyte depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do you need to correct prior to use of opioid agonists

A

fluid/electrolyte imbalances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dont use opioid agonists in

A

toxic megacolon or infectious diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

loperamide MOA

A

increases IAS and EAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

loperamide metaboolism

A

hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

loperamide excretion

A

fecal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

loperamide side effects

A

constipation - dizziness, abd pain, cramping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

loperamide black box warning

A

cardiac arrest when used in large doses - CNS effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cannot give loperamide in pts with

A

QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diphrenoxylate/atropine MOA

A

contains small amount of atropine to prevent abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diphrenoxylate/atropine onset

A

45 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diphrenoxylate/atropine metabolism

A

hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

diphrenoxylate/atropine excretion

A

fecal/urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

diphrenoxylate/atropine side effects

A

flushing, tachycardia, CNS effects, xeroderma, vomiting, toxic megacolon, urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

diphrenoxylate/atropine interactions

A

alcohol, CNS depressants, anticholinergic agents, azelastine, glucagon, prokinetic agents, eluxadoline, glycopyrrolate, opiods, kava kava, nitro, pot, zolpidem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

octreotide MOA

A

inhibits serotonin release - inhibits secretion of gastrin, VIP, insulin, glucagon, motilin, and pancreatic polypeptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

octreotide duration

A

6-12 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

octreotide metabolism

A

hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

octreotide excretion

21
Q

octreotide side effects

A

bradycardia, fatigue, HA, dizziness, puritis, hyperglycemia, hypothyroidism, cholelithiasis, abdominal pain, diarrhea, constipation, biliary obstruction, URI, cardiac arrhythmias, depression

22
Q

octreotide interactions

A

antidiabetic agents, cyclosporine, midodrine, MAOI agents, quinolones, salicylates, SSRIs

23
Q

eluxadoline MOA

A

binds to mu, kappa, and delta opioid receptors in the intestinal lumen – decreases intestinal motility without causing constipation

24
Q

eluxadoline excretion

A

fecal/urine

25
eluxadoline side effects
dizziness, drowsiness, constipation, nausea, abdominal pain, vomiting, elevated LFTs, URI
26
what can pts with cholecystectomy get when on eluxadoline
acute pancreatitis
27
eluxadoline contraindications
ETOH abuse, history of intestinal obstruction
28
eluxadoline interactions
alcohol, CNS depressants, anticholinergic agents, alosetron, gemfibrozil, opioid agonists, rosuvastatin, rifampin
29
serotonin receptor modulators
alosetron tegaserod
30
alosetron is used for
chronic (>6mo) severe IBS
31
alosetron MOA
selective 5-HT3 agonist – acts on receptors in the enteric neurons in addition to receptors in other locations centrally and peripherally – affects visceral pain, colonic transit, and alters secretions in the GI tract
32
alosetron metabolism
CYP2C9 and CYP1A2
33
alosetron side effects
constipation, fatigue, HA, abdominal pain, nausea
34
alosetron rarely causes _____ so dont use in hx of GI obstruction, crohns, diverticulitis, vasculopathy, thrombophlebitis, hypercoags
ischemic colitis
35
alosetron education
take on empty stomach to increase absorption
36
alosetron interactions
5HT3 antagonists, SSRIs, tobacco, tramadol
37
tegaserod
only available in emergency investigation drug purposes d/t risk of cardiac arrest
38
bile acid sequestrants MOA
bind to bile salts in the intestine -inhibits reuptake of bile salts, increases fecal loss of bile salt bound LDL cholesterol as well – 50% have bile acid malabsorption
39
bile acid sequestrants absorption
none
40
bile acid sequestrants side effects
abdominal pain, bloating, biliary colic, gallbladder calcification, melena, vomiting, dental erosion/discoloration, abnormal LFTs, tinnitus, bleeding issues
41
bile acid sequestrants education
do not administer within 4-6hrs of other medications - may interfere with absorption
42
bile acid sequestrants interactions
amiodarone, glucocorticoids, estrogen derivatives, loop diuretics, MTX, multiple vitamins, statins, NSAIDS, niacin, propranolol, tetracyclines, valproic acid
43
antimicrobials
rifaximin metronidazole ciprofloxacin amoxicillin neomycin
44
rifaximin MOA
blocks acetylcholine at parasympathetic receptors – antagonist of histamine and serotonin
45
rifaximin metabolism
hepatic
46
rifaximin side effects
tachycardia, mental status changes, abdominal pain, impotence, blurred vision, urinary retention, increased IOP Contraindicated in MG, hypersensitivity to belladonna, UC, myocardial ischemia
47
rifaximin contraindications
MG, hypersensitivity to belladonna, UC, myocardial ischemia
48
rifaximin interactions
amantadine, anticholinergics, cannabinoids, nitroglycerin, potassium, thiazides